* Molecular Templates Inc MTEM.OQ MTEM.O is expected
to show a
fall in quarterly revenue when it reports results on August 9
(estimated).
* The Austin Texas-based company is expected to report a
41.7% decrease in revenue to $2.575 million from $4.42 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Molecular Templates
Inc
is for a loss of 34 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Molecular
Templates Inc is $2.5, above its last closing price of $0.56.
This summary was machine generated August 8 at 02:07 GMT. All
figures in US dollars unless otherwise stated